DRW Securities, LLC

SEC CIK: 0001481986
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by DRW Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2025

Holdings of RARE by DRW Securities, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−12,266−100.0%	Sold out	Holders
Q3 2025	12,266	$358.1K	<0.1%	−2,353−16.1%	Reduced	Holders
Q2 2025	14,619	$531.5K	<0.1%	+14,619	New	Holders